BCYC Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | Jordan Veronica GH | director | 11,500 | A-Award | A | 11,500 | 29.60 | 340,400.00 |
| 2023-01-03 | Jordan Veronica GH | director | 10,750 | A-Award | A | 5,750 | 0.00 | 0.00 |
| 2023-01-03 | Crockett Nigel | officer: Chief Business Officer | 35,000 | A-Award | A | 35,000 | 29.60 | 1,036,000.00 |
| 2023-01-03 | Crockett Nigel | officer: Chief Business Officer | 30,699 | S-Sale | D | 1,801 | 29.06 | 52,337.06 |
| 2023-01-03 | Crockett Nigel | officer: Chief Business Officer | 32,500 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2023-01-03 | Winter Gregory Paul | director | 11,500 | A-Award | A | 11,500 | 29.60 | 340,400.00 |
| 2023-01-03 | Winter Gregory Paul | director | 174,677 | A-Award | A | 5,750 | 0.00 | 0.00 |
| 2023-01-03 | Milnes Alistair | officer: Chief Operating Officer | 35,000 | A-Award | A | 35,000 | 29.60 | 1,036,000.00 |
| 2023-01-03 | Milnes Alistair | officer: Chief Operating Officer | 38,179 | S-Sale | D | 1,801 | 29.06 | 52,337.06 |
| 2023-01-03 | Milnes Alistair | officer: Chief Operating Officer | 39,980 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2023-01-03 | Smethurst Dominic | officer: Chief Medical Officer | 35,000 | A-Award | A | 35,000 | 29.60 | 1,036,000.00 |
| 2023-01-03 | Smethurst Dominic | officer: Chief Medical Officer | 36,699 | S-Sale | D | 1,801 | 29.06 | 52,337.06 |
| 2023-01-03 | Smethurst Dominic | officer: Chief Medical Officer | 38,500 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2023-01-03 | Keen Nicholas | officer: Chief Scientific Officer | 35,000 | A-Award | A | 35,000 | 29.60 | 1,036,000.00 |
| 2023-01-03 | Keen Nicholas | officer: Chief Scientific Officer | 39,160 | S-Sale | D | 1,817 | 29.06 | 52,802.02 |
| 2023-01-03 | Keen Nicholas | officer: Chief Scientific Officer | 40,977 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2023-01-03 | Skynner Michael | officer: Chief Technology Officer | 35,000 | A-Award | A | 35,000 | 29.60 | 1,036,000.00 |
| 2023-01-03 | Skynner Michael | officer: Chief Technology Officer | 71,822 | S-Sale | D | 1,801 | 29.06 | 52,337.06 |
| 2023-01-03 | Skynner Michael | officer: Chief Technology Officer | 73,623 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2023-01-03 | Bourque Janice | director | 11,500 | A-Award | A | 11,500 | 29.60 | 340,400.00 |
| 2023-01-03 | Bourque Janice | director | 10,750 | A-Award | A | 5,750 | 0.00 | 0.00 |
| 2023-01-03 | Kalowski Lee | officer: President and CFO | 35,000 | A-Award | A | 35,000 | 29.60 | 1,036,000.00 |
| 2023-01-03 | Kalowski Lee | officer: President and CFO | 30,685 | S-Sale | D | 1,815 | 29.06 | 52,743.90 |
| 2023-01-03 | Kalowski Lee | officer: President and CFO | 32,500 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2023-01-03 | Legault Pierre | director | 23,000 | A-Award | A | 23,000 | 29.60 | 680,800.00 |
| 2023-01-03 | Legault Pierre | director | 21,500 | A-Award | A | 11,500 | 0.00 | 0.00 |
| 2023-01-03 | Lee Kevin | director, officer: Chief Executive Officer | 115,000 | A-Award | A | 115,000 | 29.60 | 3,404,000.00 |
| 2023-01-03 | Lee Kevin | director, officer: Chief Executive Officer | 326,585 | S-Sale | D | 6,000 | 29.06 | 174,360.00 |
| 2023-01-03 | Lee Kevin | director, officer: Chief Executive Officer | 332,585 | A-Award | A | 57,500 | 0.00 | 0.00 |
| 2023-01-03 | Gutierrez-Ramos Jose-Carlos | director | 11,500 | A-Award | A | 11,500 | 29.60 | 340,400.00 |
| 2023-01-03 | Gutierrez-Ramos Jose-Carlos | director | 10,750 | A-Award | A | 5,750 | 0.00 | 0.00 |
| 2023-01-03 | Kender Richard N | director | 11,500 | A-Award | A | 11,500 | 29.60 | 340,400.00 |
| 2023-01-03 | Kender Richard N | director | 10,750 | A-Award | A | 5,750 | 0.00 | 0.00 |
| 2022-03-25 | Milnes Alistair | officer: Chief Operating Officer | 46,845 | M-Exempt | A | 5,155 | 20.12 | 103,718.60 |
| 2022-03-25 | Milnes Alistair | officer: Chief Operating Officer | 22,480 | M-Exempt | A | 5,155 | 20.12 | 103,718.60 |
| 2022-01-03 | Jordan Veronica GH | director | 10,000 | A-Award | A | 10,000 | 60.87 | 608,700.00 |
| 2022-01-03 | Jordan Veronica GH | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-01-03 | Winter Gregory Paul | director | 10,000 | A-Award | A | 10,000 | 60.87 | 608,700.00 |
| 2022-01-03 | Winter Gregory Paul | director | 168,927 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-01-03 | Milnes Alistair | officer: Chief Operating Officer | 100,000 | A-Award | A | 100,000 | 60.87 | 6,087,000.00 |
| 2022-01-03 | Milnes Alistair | officer: Chief Operating Officer | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2022-01-03 | Bourque Janice | director | 10,000 | A-Award | A | 10,000 | 60.87 | 608,700.00 |
| 2022-01-03 | Bourque Janice | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-01-03 | Crockett Nigel | officer: Chief Business Officer | 30,000 | A-Award | A | 30,000 | 60.87 | 1,826,100.00 |
| 2022-01-03 | Crockett Nigel | officer: Chief Business Officer | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2022-01-03 | Gutierrez-Ramos Jose-Carlos | director | 10,000 | A-Award | A | 10,000 | 60.87 | 608,700.00 |
| 2022-01-03 | Gutierrez-Ramos Jose-Carlos | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-01-03 | Kalowski Lee | officer: President and CFO | 30,000 | A-Award | A | 30,000 | 60.87 | 1,826,100.00 |
| 2022-01-03 | Kalowski Lee | officer: President and CFO | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2022-01-03 | Keen Nicholas | officer: Chief Scientific Officer | 30,000 | A-Award | A | 30,000 | 60.87 | 1,826,100.00 |
| 2022-01-03 | Keen Nicholas | officer: Chief Scientific Officer | 23,477 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2022-01-03 | Kender Richard N | director | 10,000 | A-Award | A | 10,000 | 60.87 | 608,700.00 |
| 2022-01-03 | Kender Richard N | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-01-03 | Lee Kevin | director, officer: Chief Executive Officer | 100,000 | A-Award | A | 100,000 | 60.87 | 6,087,000.00 |
| 2022-01-03 | Lee Kevin | director, officer: Chief Executive Officer | 275,085 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2022-01-03 | Legault Pierre | director | 20,000 | A-Award | A | 20,000 | 60.87 | 1,217,400.00 |
| 2022-01-03 | Legault Pierre | director | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2022-01-03 | Skynner Michael | officer: Chief Technology Officer | 30,000 | A-Award | A | 30,000 | 60.87 | 1,826,100.00 |
| 2022-01-03 | Skynner Michael | officer: Chief Technology Officer | 56,123 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2022-01-03 | Smethurst Dominic | officer: Chief Medical Officer | 30,000 | A-Award | A | 30,000 | 60.87 | 1,826,100.00 |
| 2022-01-03 | Smethurst Dominic | officer: Chief Medical Officer | 21,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2021-12-22 | Legault Pierre | director | 23,312 | M-Exempt | D | 97,860 | 8.48 | 829,852.80 |
| 2021-12-22 | Legault Pierre | director | 121,172 | M-Exempt | D | 44,537 | 8.44 | 375,892.28 |
| 2021-12-22 | Legault Pierre | director | 165,709 | M-Exempt | D | 7,603 | 8.41 | 63,941.23 |
| 2021-12-22 | Legault Pierre | director | 0 | S-Sale | D | 97,860 | 58.01 | 5,676,858.60 |
| 2021-12-22 | Legault Pierre | director | 97,860 | M-Exempt | A | 97,860 | 8.48 | 829,852.80 |
| 2021-12-21 | Keen Nicholas | officer: Chief Scientific Officer | 161,927 | M-Exempt | D | 15,477 | 14.00 | 216,678.00 |
| 2021-12-21 | Keen Nicholas | officer: Chief Scientific Officer | 15,477 | M-Exempt | A | 15,477 | 14.00 | 216,678.00 |
| 2021-12-21 | Legault Pierre | director | 0 | S-Sale | D | 44,537 | 57.11 | 2,543,508.07 |
| 2021-12-21 | Legault Pierre | director | 44,537 | M-Exempt | A | 44,537 | 8.44 | 375,892.28 |
| 2021-12-20 | Legault Pierre | director | 0 | S-Sale | D | 7,603 | 57.02 | 433,523.06 |
| 2021-12-20 | Legault Pierre | director | 7,603 | M-Exempt | A | 7,603 | 8.41 | 63,941.23 |
| 2021-10-18 | Lee Kevin | director, officer: Chief Executive Officer | 225,085 | S-Sale | D | 49 | 60.00 | 2,940.00 |
| 2021-10-15 | Lee Kevin | director, officer: Chief Executive Officer | 225,134 | S-Sale | D | 320 | 60.05 | 19,216.00 |
| 2021-10-14 | Lee Kevin | director, officer: Chief Executive Officer | 225,454 | S-Sale | D | 4,631 | 60.00 | 277,860.00 |
| 2021-10-11 | Lee Kevin | director, officer: Chief Executive Officer | 230,085 | S-Sale | D | 598 | 54.67 | 32,692.66 |
| 2021-10-11 | Lee Kevin | director, officer: Chief Executive Officer | 230,683 | S-Sale | D | 4,402 | 53.77 | 236,695.54 |
| 2021-10-05 | Keen Nicholas | officer: Chief Scientific Officer | 0 | S-Sale | D | 2,178 | 45.10 | 98,227.80 |
| 2021-10-01 | Keen Nicholas | officer: Chief Scientific Officer | 2,178 | S-Sale | D | 1,188 | 45.00 | 53,460.00 |
| 2021-09-23 | Smethurst Dominic | officer: Chief Medical Officer | 6,000 | M-Exempt | A | 6,000 | 18.55 | 111,300.00 |
| 2021-09-23 | Smethurst Dominic | officer: Chief Medical Officer | 114,000 | M-Exempt | D | 6,000 | 18.55 | 111,300.00 |
| 2021-09-16 | Keen Nicholas | officer: Chief Scientific Officer | 3,366 | S-Sale | D | 1,955 | 45.01 | 87,994.55 |
| 2021-09-15 | Keen Nicholas | officer: Chief Scientific Officer | 5,321 | S-Sale | D | 3,000 | 45.00 | 135,000.00 |
| 2021-09-02 | Kalowski Lee | officer: President and CFO | 0 | S-Sale | D | 10,000 | 9.82 | 98,200.00 |
| 2021-09-02 | Kalowski Lee | officer: President and CFO | 50,000 | M-Exempt | D | 10,000 | 9.82 | 98,200.00 |
| 2021-09-02 | Keen Nicholas | officer: Chief Scientific Officer | 8,321 | S-Sale | D | 10,000 | 40.00 | 400,000.00 |
| 2021-09-02 | Kalowski Lee | officer: President and CFO | 10,000 | M-Exempt | A | 10,000 | 9.82 | 98,200.00 |
| 2021-09-02 | Lee Kevin | director, officer: Chief Executive Officer | 235,085 | S-Sale | D | 5,000 | 40.00 | 200,000.00 |
| 2021-09-01 | Lee Kevin | director, officer: Chief Executive Officer | 241,881 | S-Sale | D | 17,098 | 37.52 | 641,516.96 |
| 2021-09-01 | Lee Kevin | director, officer: Chief Executive Officer | 240,085 | S-Sale | D | 1,796 | 38.08 | 68,391.68 |
| 2021-09-01 | Lee Kevin | director, officer: Chief Executive Officer | 306,252 | M-Exempt | D | 22,890 | 14.00 | 320,460.00 |
| 2021-09-01 | Lee Kevin | director, officer: Chief Executive Officer | 267,170 | M-Exempt | A | 22,890 | 14.00 | 320,460.00 |
| 2021-09-01 | Lee Kevin | director, officer: Chief Executive Officer | 258,979 | S-Sale | D | 8,191 | 36.38 | 297,988.58 |
| 2021-08-31 | Lee Kevin | director, officer: Chief Executive Officer | 329,142 | M-Exempt | D | 10,420 | 14.00 | 145,880.00 |
| 2021-08-31 | Lee Kevin | director, officer: Chief Executive Officer | 255,505 | M-Exempt | A | 10,420 | 14.00 | 145,880.00 |
| 2021-08-31 | Lee Kevin | director, officer: Chief Executive Officer | 245,552 | S-Sale | D | 9,953 | 36.23 | 360,597.19 |
| 2021-08-31 | Lee Kevin | director, officer: Chief Executive Officer | 244,280 | S-Sale | D | 1,272 | 37.08 | 47,165.76 |
| 2021-08-27 | Lee Kevin | director, officer: Chief Executive Officer | 339,562 | M-Exempt | D | 1,808 | 14.00 | 25,312.00 |
| 2021-08-27 | Kalowski Lee | officer: President and CFO | 0 | S-Sale | D | 7,950 | 35.15 | 279,442.50 |
| 2021-08-27 | Kalowski Lee | officer: President and CFO | 7,950 | M-Exempt | A | 7,950 | 35.15 | 279,442.50 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.